These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30796985)

  • 1. Update on the contraceptive contraindications.
    Serfaty D
    J Gynecol Obstet Hum Reprod; 2019 May; 48(5):297-307. PubMed ID: 30796985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.
    Lauring JR; Lehman EB; Deimling TA; Legro RS; Chuang CH
    Am J Obstet Gynecol; 2016 Sep; 215(3):330.e1-7. PubMed ID: 27059507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):878-83. PubMed ID: 21734635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACOG Practice Bulletin. The use of hormonal contraception in women with coexisting medical conditions. Number 18, July 2000.
    ACOG Committee on Practice Bulletins-Gynecology
    Int J Gynaecol Obstet; 2001 Oct; 75(1):93-106. PubMed ID: 11732484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.
    Tepper NK; Krashin JW; Curtis KM; Cox S; Whiteman MK
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):990-994. PubMed ID: 28934178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraceptive choices in women with coagulation disorders.
    Comp PC; Zacur HA
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(24):449-52. PubMed ID: 22717514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestin-only oral contraception: a comprehensive review.
    McCann MF; Potter LS
    Contraception; 1994 Dec; 50(6 Suppl 1):S1-195. PubMed ID: 10226677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions.
    Obstet Gynecol; 2019 Feb; 133(2):e128-e150. PubMed ID: 30681544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
    Reid R;
    J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACOG Practice Bulletin No. 206 Summary: Use of Hormonal Contraception in Women With Coexisting Medical Conditions.
    Obstet Gynecol; 2019 Feb; 133(2):396-399. PubMed ID: 30681537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contraceptive Steroids, age, and the cardiovascular system.
    Plunkett ER
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):747-51. PubMed ID: 7065055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current challenges in contraception in adolescents and young women.
    Cornet A
    Curr Opin Obstet Gynecol; 2013 Mar; 25 Suppl 1():S1-10. PubMed ID: 23370330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal contraception].
    Van Cauwenberge JR
    Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives in relation to breast cancer.
    Malone KE; Daling JR; Weiss NS
    Epidemiol Rev; 1993; 15(1):80-97. PubMed ID: 8405215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy.
    Bhakta J; Bainbridge J; Borgelt L
    Epilepsy Behav; 2015 Nov; 52(Pt A):212-7. PubMed ID: 26460786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormonal contraception--side effects and surgical aspects (author's transl)].
    Göretzlehner G; Carol W; Köhler G
    Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHO scientific group meeting on cardiovascular disease and steroid hormone contraceptives.
    Wkly Epidemiol Rec; 1997 Nov; 72(48):361-3. PubMed ID: 9409187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.